Results 71 to 80 of about 19,576 (88)

Extracorporeal Blood Purification Therapy to Deal a Deferasirox Induced Life‐Threatening Hepatic Encephalopathy in a Septic Child With Sickle‐Cell Disease: A Case Report

open access: yesJournal of Clinical Apheresis, Volume 40, Issue 3, June 2025.
ABSTRACT This report details a rare pediatric case of hyperammonemic encephalopathy caused by the oral iron chelating drug deferasirox (DFR) in a septic patient. It is our contention that this study lends support to the existing literature, as it describes the case of a 15‐year‐old female patient with a history of sickle‐cell disease who presented with
E. Rossetti   +7 more
wiley   +1 more source

Use of Parathyroid Hormone Assay after Thyroidectomy: A Survey of US and European Surgeons [PDF]

open access: yes, 2013
Brietzke S   +5 more
core   +1 more source

Prepartum Nutritional Strategies to Manage Postpartum Hypocalcemia [PDF]

open access: yes, 2015
This information was presented at the 2015 Cornell Nutrition Conference for Feed Manufacturers, organized by the Department of Animal Science In the College of Agriculture and Life Sciences at Cornell University.
Kirk, D.   +5 more
core  

Hypocalcemia After Thyroidectomy in Patients Taking Proton Pump Inhibitors

open access: yesLaryngoscope Investigative Otolaryngology, Volume 10, Issue 3, June 2025.
Patients taking proton pump inhibitors may be more likely to experience of short‐term and permanent hypocalcemia after thyroid surgery. The current study is the largest to date, indicating an increased risk of hypocalcemia after thyroidectomy in patients taking proton pump inhibitors.
Maxwell Rossip   +3 more
wiley   +1 more source

Venetoclax Combined With Chemotherapy in Pediatric and Adolescent/Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia

open access: yesPediatric Blood &Cancer, Volume 72, Issue 6, June 2025.
ABSTRACT Background Acute lymphoblastic leukemia (ALL) is the most common childhood cancer, and although many patients respond to induction therapy, those who relapse or have refractory disease face a poor prognosis. Venetoclax has promising preclinical and clinical activity in ALL.
Andrew E. Place   +21 more
wiley   +1 more source

Spontaneous haemoperitoneum secondary to mast cell neoplasia and presumed splenic abscess rupture in a cat

open access: yesVeterinary Record Case Reports, Volume 13, Issue 2, June 2025.
Abstract A geriatric feline was presented to a university teaching hospital for lethargy and inappetence. The patient was subsequently diagnosed with spontaneous haemoperitoneum secondary to rupture of a splenic mass and was taken to surgery for splenectomy following appropriate stabilisation measures.
Jenna Collins   +2 more
wiley   +1 more source

What is the best workup for hypocalcemia? [PDF]

open access: yes, 2008
Unexplained hypocalcemia can usually be diagnosed by a limited number of serum tests when the cause isn't obvious from the history (recent neck surgery or renal failure): calcium corrected for serum albumin); creatinine; phosphorus; magnesium ...
Bosworth, Michele   +2 more
core  

Resolution of third‐degree atrioventricular block after antibiotic therapy in a dog (Canis lupus familiaris) with urinary tract infection

open access: yesVeterinary Record Case Reports, Volume 13, Issue 2, June 2025.
Abstract A 15‐year‐old, spayed, female Boxer dog presented to an emergency facility for collapsing episodes. Third‐degree atrioventricular block that was non‐responsive to atropine was diagnosed on electrocardiography. Initial diagnostics revealed a concurrent urinary tract infection and renal azotaemia.
Jacob Ryave   +2 more
wiley   +1 more source

Denosumab-induced severe hypocalcemia in a patient with Crohn's disease [PDF]

open access: yes, 2014
Osteoporosis occurs with increased prevalence in individuals with inflammatory bowel disease (IBD), and as such, these patients are at risk for osteoporosis-related fractures.
Katta, Natraj   +3 more
core  

The Effects of Denosumab Treatment on Pain and Function Beyond Bone Density in Patients With Postmenopausal Osteoporosis: A Prospective Study

open access: yesOrthopaedic Surgery, Volume 17, Issue 6, Page 1644-1655, June 2025.
Following 12 months of denosumab treatment in patients with PMOP and increasing BMD, there was a significant improvement in pain and functional disability, which was more pronounced in patients with a history of fragility fractures (mainly vertebral fractures).
Miao Zheng   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy